Abraham A. Kroon

Prof. Abraham A. Kroon

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AJArmand Jaminon
Armand Jaminon
KRKoen Reesink
Koen Reesink
AKAbraham A. Kroon
Abraham A. Kroon
Leon SchurgersLeon Schurgers
Leon Schurgers
Arterial remodeling refers to the structural and functional changes of the vessel wall that occur in response to disease, injury, or aging. Vascular smooth muscle cells (VSMC) play a pivotal role in regulating the remodeling processes of the vessel wall. Phenotypic switching of VSMC involves oxidative stress-induced extracellular vesicle release, driving calcification processes. The VSMC phenotype is relevant to plaque initiation, development and stability, whereas, in the media, the VSMC phenotype is important in maintaining tissue elasticity, wall stress homeostasis and vessel stiffness. Clinically, assessment of arterial remodeling is a challenge; particularly distinguishing intimal and medial involvement, and their contributions to vessel wall remodeling. The limitations pertain to imaging resolution and sensitivity, so methodological development is focused on improving those. Moreover, the integration of data across the microscopic (i.e., cell-tissue) and macroscopic (i.e., vessel-system) scale for correct interpretation is innately challenging, because of the multiple biophysical and biochemical factors involved. In the present review, we describe the arterial remodeling processes that govern arterial stiffening, atherosclerosis and calcification, with a particular focus on VSMC phenotypic switching. Additionally, we review clinically applicable methodologies to assess arterial remodeling and the latest developments in these, seeking to unravel the ubiquitous corroborator of vascular pathology that calcification appears to be.

1 January 2012 in Frontiers in Genetics
Verified
Journal Article
Open access
BVBernard J. van Varik
Bernard J. van Varik
RRRoger J. M. W. Rennenberg
Roger J. M. W. Rennenberg
CRChris PM Reutlingsperger
Chris PM Reutlingsperger
AKAbraham A. Kroon
Abraham A. Kroon
PLPeter De Leeuw
Peter De Leeuw
Leon SchurgersLeon Schurgers
Leon Schurgers
Vascular disease is still the leading cause of morbidity and mortality in the Western world, and the primary cause of myocardial infarction, stroke, and ischemia. The biology of vascular disease is complex and still poorly understood in terms of causes and consequences. Vascular function is determined by structural and functional properties of the arterial vascular wall. Arterial stiffness, that is a pathological alteration of the vascular wall, ultimately results in target-organ damage and increased mortality. Arterial remodeling is accelerated under conditions that adversely affect the balance between arterial function and structure such as hypertension, atherosclerosis, diabetes mellitus, chronic kidney disease, inflammatory disease, lifestyle aspects (smoking), drugs (vitamin K antagonists), and genetic abnormalities [e.g., pseudoxanthoma elasticum (PXE), Marfan's disease]. The aim of this review is to provide an overview of the complex mechanisms and different factors that underlie arterial remodeling, learning from single gene defect diseases like PXE, and PXE-like, Marfan's disease and Keutel syndrome in vascular remodeling.

1 March 2009 in JACC
Verified
Journal Article
Closed access
RKRoland van Kimmenade
Roland van Kimmenade
JJJames Januzzi
James Januzzi
JBJaap A. Bakker
Jaap A. Bakker
AHAlphonse J. Houben
Alphonse J. Houben
RRRoger Rennenberg
Roger Rennenberg
YPYigal M. Pinto
Yigal M. Pinto

1 October 2018 in Hypertension
Verified
Journal Article
Closed access
TZTan Lai Zhou
Tan Lai Zhou
RHRonald M.A. Henry
Ronald M.A. Henry
CSCoen D.A. Stehouwer
Coen D.A. Stehouwer
TSThomas T. van Sloten
Thomas T. van Sloten
KRKoen D. Reesink
Koen D. Reesink
AKAbraham A. Kroon
Abraham A. Kroon
Greater very short- to midterm blood pressure variability (BPV) has been associated with an increased cardiovascular disease risk, especially stroke. However, this link remains incompletely understood. We hypothesized that increased arterial stiffness and maladaptive carotid arterial remodeling may underlie this association. We, therefore, investigated the association between very short- to midterm systolic BPV, aortic and carotid stiffness and carotid arterial remodeling using cross-sectional data from The Maastricht Study (aged 60±8 years; 53% men). Aortic (carotid-femoral pulse wave velocity, n=1671) and carotid stiffness (ultrasonography, n=1690) were assessed. A composite index of systolic BPV was derived by standardizing and averaging systolic within-visit, 24-hour, and 7-day BPV. We performed linear regression analyses with adjustment for age, sex, glucose metabolism status, mean arterial pressure, and cardiovascular risk factors. A 1-SD greater systolic BPV was statistically significantly associated with 0.10 m/s (95% CI, 0.01–0.20) greater carotid-femoral pulse wave velocity, but not with carotid distensibility (−0.033×10 −3 /kPa [−0.255 to 0.190]). In addition, a 1-SD greater systolic BPV was statistically significantly associated with greater carotid circumferential wall tension (0.84 dyne/cm [0.51–1.17]), circumferential wall stress (0.79 kPa [0.031–1.27]), and intima-media thickness (8.6 µm [1.0–16.3]). These results are indicative of maladaptive carotid remodeling, as circumferential wall tension and stress were not normalized despite greater intima-media thickness. In conclusion, greater very short- to midterm BPV is associated with greater aortic stiffness and maladaptive carotid arterial remodeling, but not with carotid stiffness. These findings may explain, at least partially, the increased BPV-associated cardiovascular disease risk, in particular stroke.

8 July 2020 in EP Europace
Verified
Journal Article
Open access
RWRuben R De With
Ruben R De With
ÖEÖmer Erküner
Ömer Erküner
MRMichiel Rienstra
Michiel Rienstra
BNBao-Oanh Nguyen
Bao-Oanh Nguyen
FKFrank W J Körver
Frank W J Körver
IGIsabelle C Van Gelder
Isabelle C Van Gelder
Aims: Atrial fibrillation (AF) often starts as a paroxysmal self-terminating arrhythmia. Limited information is available on AF patterns and episode duration of paroxysmal AF. In paroxysmal AF patients, we longitudinally studied the temporal AF patterns, the association with clinical characteristics, and prevalence of AF progression. Methods and results: In this interim analysis of the Reappraisal of AF: Interaction Between HyperCoagulability, Electrical Remodelling, and Vascular Destabilisation in the Progression of AF (RACE V) registry, 202 patients with paroxysmal AF were followed with continuous rhythm monitoring (implantable loop recorder or pacemaker) for 6 months. Mean age was 64 ± 9 years, 42% were women. Atrial fibrillation history was 2.1 (0.5–4.4) years, CHA2DS2-VASc 1.9 ± 1.3, 101 (50%) had hypertension, 69 (34%) heart failure. One-third had no AF during follow-up. Patients with long episodes (>12 hours) were often men with more comorbidities (heart failure, coronary artery disease, higher left ventricular mass). Patients with higher AF burden (>2.5%) were older with more comorbidities (worse renal function, higher calcium score, thicker intima media thickness). In 179 (89%) patients, 1-year rhythm follow-up was available. On a quarterly basis, average daily AF burden increased from 3.2% to 3.8%, 5.2%, and 6.1%. Compared to the first 6 months, 111 (62%) patients remained stable during the second 6 months, 39 (22%) showed progression to longer AF episodes, 8 (3%) developed persistent AF, and 29 (16%) patients showed AF regression. Conclusions: In paroxysmal AF, temporal patterns differ suggesting that paroxysmal AF is not one entity. Atrial fibrillation burden is low and determined by number of comorbidities. Atrial fibrillation progression occurred in a substantial number. Trial registration number: Clinicaltrials.gov identifier NCT02726698.

1 February 2021 in Radiology
Verified
Journal Article
Closed access
LVLaura W. M. Vergoossen
Laura W. M. Vergoossen
JJJacobus F A Jansen
Jacobus F A Jansen
TSThomas T. van Sloten
Thomas T. van Sloten
CSCoen D. A. Stehouwer
Coen D. A. Stehouwer
NSNicolaas Schaper
Nicolaas Schaper
WBWalter H. Backes
Walter H. Backes
White matter hyperintensity volume, local efficiency, and information processing speed scores are interrelated, and local network alterations as response to white matter abnormality explain detrime... Background Lesions of cerebral small vessel disease, such as white matter hyperintensities (WMHs) in individuals with cardiometabolic risk factors, interfere with the trajectories of the white matt...